or
forgot password

Breast Cancer Siblings Database


N/A
18 Years
N/A
Open (Enrolling)
Both
Breast Cancer

Thank you

Trial Information

Breast Cancer Siblings Database


OBJECTIVES:

- Collect blood samples and medical and background information from patients with
invasive breast cancer and their affected or unaffected siblings.

OUTLINE: Patients and their siblings undergo blood collection. They also complete medical
and background questionnaires.

Patients and their siblings are followed annually for 5 years.

PROJECTED ACCRUAL: A total of 1,000 patients and siblings will be accrued for this study.

Inclusion Criteria


DISEASE CHARACTERISTICS:

- Meets 1 of the following criteria:

- Pathologically confirmed invasive breast cancer (patient)

- No ductal carcinoma in situ

- Affected OR unaffected sibling

- Affected sibling must have had (or currently has) breast cancer only

- Unaffected sibling must be female

- No deceased siblings

- Must be a full-blood related sibling

- Patients receiving treatment on clinical trial ECOG-E1Y97 or ECOG-E3Y92 are not
eligible

PATIENT CHARACTERISTICS:

- Not specified

PRIOR CONCURRENT THERAPY:

- Not specified

Type of Study:

Observational

Study Design:

N/A

Outcome Measure:

Collection of blood samples and medical and background information

Principal Investigator

Richard A. Shapiro, MD

Investigator Role:

Study Chair

Investigator Affiliation:

GenBasix Incorporated

Authority:

Unspecified

Study ID:

CDR0000529353

NCT ID:

NCT00445562

Start Date:

January 2001

Completion Date:

Related Keywords:

  • Breast Cancer
  • male breast cancer
  • recurrent breast cancer
  • stage IA breast cancer
  • stage IB breast cancer
  • stage II breast cancer
  • stage IIIA breast cancer
  • stage IIIB breast cancer
  • stage IIIC breast cancer
  • stage IV breast cancer
  • Breast Neoplasms

Name

Location
GenBasix Incorporated Duarte, California  91010